Company Reports 204% Revenue Growth compared with Q1 2025. Increased regulatory enforcement, FDA’s pivot on flavored vapor products, and plans to launch America’s first age-gated disposable, bode well for Charlie’s. COSTA MESA, CA, May 20, 2026 (GLOBE NEWSWIRE) — Charlie’s Holdings, Inc. (OTCQB: CHUC) (“Charlie’s” or the “Company”), an industry leader in the premium vapor products space, today reported results for the three months ended March 31, 2026, and provided an update on recent business highlights.  Key Financial Highlights for Q1 2026 (compared with Q1 2025)Revenue increased 204% to $4.8 million Gross profit increased 206% to $1.2 million Operating expenses increased 70% to $2.2 million Net loss decreased 14% to $1.1 millionRecent Business HighlightsThe Company achieved 204% revenue growth driven by significant expansion...

PARIS and CAMBRIDGE, Mass., May 20, 2026 (GLOBE NEWSWIRE) — NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – “Nanobiotix” or the “Company”), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer and other major diseases, announces the launch, subject to market and other conditions, of an approximately €75 million global follow-on offering (representing approximately $87 million) consisting of (i) a public offering of its American Depositary Shares (“ADSs”), each ADS representing one ordinary share, €0.03 nominal value per share (each an “Ordinary Share”), of the Company, in the United States (the “U.S. Offering”) and (ii) an offering of (a) its Ordinary Shares and (b) pre-funded warrants to subscribe for Ordinary Shares (the “PFW”), exclusively addressed...

PARIS and CAMBRIDGE, Mass., May 20, 2026 (GLOBE NEWSWIRE) — NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – “Nanobiotix” or the “Company”), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer and other major diseases, announces the launch, subject to market and other conditions, of an approximately €75 million global follow-on offering (representing approximately $87 million) consisting of (i) a public offering of its American Depositary Shares (“ADSs”), each ADS representing one ordinary share, €0.03 nominal value per share (each an “Ordinary Share”), of the Company, in the United States (the “U.S. Offering”) and (ii) an offering of (a) its Ordinary Shares and (b) pre-funded warrants to subscribe for Ordinary Shares (the “PFW”), exclusively addressed...

NEW YORK, May 20, 2026 (GLOBE NEWSWIRE) — Figure Technology Solutions (Nasdaq: FIGR; OPEN: FGRS), the leading blockchain-native capital marketplace for the origination, funding, sale and trading of tokenized assets, today announced the company will be participating in the following upcoming investor conferences:Bernstein 42nd Annual Strategic Decisions Conference (New York, NY)Presentation on Wednesday, May 27th at 3:30 p.m. ETPiper Sandler Global Exchange & FinTech Conference (New York, NY)Presentation on Wednesday, June 3rd at 2:00 p.m. ETInterested parties may access a live audio webcast of the presentations by visiting https://investors.figure.com/. Following the presentation, a recording will be available for replay for at least 90 days at the same link. About Figure Technology Solutions, Inc Figure Technology Solutions,...

VS&Co Board and Management are Delivering Significant Operational and TSR Outperformance Under New Leadership and “Path to Potential” Strategy BBRC’s Campaign Ignores Meaningful Progress and Seeks to Disrupt Path to Potential with Self-Interested Narratives and Misleading Claims VS&Co Urges Shareholders to Vote “FOR” All Highly Qualified Directors at the 2026 Annual Meeting of Shareholders REYNOLDSBURG, Ohio, May 20, 2026 (GLOBE NEWSWIRE) — Victoria’s Secret & Co. (“VS&Co” or the “Company”) (NYSE: VSCO) today announced that it has filed a detailed investor presentation titled “Vote for Victoria’s Secret’s Board and Our Continued Momentum.” The presentation highlights the Company’s strong operational and financial momentum under its Path to Potential strategy, as well as the decisive actions taken by the Board...

WALTHAM, Mass., May 20, 2026 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that it has granted inducement equity awards to 17 newly hired employees. The awards were made as an inducement material to the newly hired employees’ acceptance of employment with Dyne in accordance with Nasdaq Listing Rule 5635(c)(4). The inducement equity awards consisted of non-statutory stock options to purchase up to an aggregate of 296,500 shares of Dyne’s common stock at a per share exercise price equal to the closing price of Dyne’s common stock on The Nasdaq Global Select Market on May 20, 2026, and restricted stock units with respect to an aggregate of 94,100 shares of Dyne’s common...

Los Angeles, CA, May 20, 2026 (GLOBE NEWSWIRE) — Aperture AC (the “Company”) announced today the pricing of its initial public offering of 9,000,000 units at a price of $10.00 per unit. The units are expected to be listed on the Nasdaq Capital Market (“Nasdaq”) and begin trading tomorrow, May 21, 2026, under the ticker symbol “APURU.” Each unit consists of one Class A ordinary share and one right (the “Share Right”) to receive one-fourth (1/4) of one Class A ordinary share upon the consummation of an initial business combination. Once the securities constituting the units begin separate trading, the Class A ordinary shares and Share Rights are expected to be listed on Nasdaq under the symbols “APUR” and “APURR,” respectively. The offering is expected to close on May 22, 2026, subject to customary closing conditions. The Company...

Sale of Clean Earth and Spin-off of Harsco Environmental and Rail expected to be completed on June 1, 2026 Enviri stockholders to receive $15.00 per share at closing, after debt repayment, transaction costs and other financial considerations Effective date for distribution in Spin-off of Harsco Environmental and Rail is expected to be June 1, 2026 (the “Effective Date”) Enviri stockholders will receive one share of New Enviri common stock for every three shares of Enviri common stock on June 1, 2026 Enviri II Corporation (“New Enviri”) “When Issued” trading expected to begin on May 27, 2026 under symbol “NVRI WI” and “Regular Way” trading expected to begin on June 2, 2026 under the new name “Enviri Corporation” and symbol “NVRI”PHILADELPHIA, May 20, 2026 (GLOBE NEWSWIRE) — As previously announced, Enviri Corporation (NYSE: NVRI)...